US Bancorp DE boosted its position in shares of Monsanto Co. (NYSE:MON) by 1.5% during the third quarter, Holdings Channel reports. The firm owned 324,768 shares of the company’s stock after buying an additional 4,882 shares during the period. US Bancorp DE’s holdings in Monsanto were worth $33,192,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. IndexIQ Advisors LLC increased its position in Monsanto by 4.4% in the third quarter. IndexIQ Advisors LLC now owns 67,355 shares of the company’s stock worth $6,884,000 after buying an additional 2,824 shares in the last quarter. TIAA CREF Trust Co. FSB MO increased its position in Monsanto by 8.2% in the third quarter. TIAA CREF Trust Co. FSB MO now owns 38,059 shares of the company’s stock worth $3,890,000 after buying an additional 2,886 shares in the last quarter. M&T Bank Corp increased its position in Monsanto by 1.0% in the third quarter. M&T Bank Corp now owns 243,178 shares of the company’s stock worth $24,853,000 after buying an additional 2,365 shares in the last quarter. Guyasuta Investment Advisors Inc. bought a new position in Monsanto during the third quarter worth approximately $243,000. Finally, CIBC World Markets Inc. increased its position in Monsanto by 54.9% in the third quarter. CIBC World Markets Inc. now owns 10,253 shares of the company’s stock worth $1,048,000 after buying an additional 3,633 shares in the last quarter. Institutional investors own 73.94% of the company’s stock.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Shares of Monsanto Co. (NYSE:MON) traded up 0.3243% during trading on Tuesday, reaching $102.3609. The company had a trading volume of 121,379 shares. Monsanto Co. has a 12 month low of $83.73 and a 12 month high of $114.26. The stock has a 50 day moving average price of $100.97 and a 200 day moving average price of $104.18. The firm has a market capitalization of $44.83 billion, a PE ratio of 34.2573 and a beta of 1.01.

Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business had revenue of $2.56 billion for the quarter, compared to the consensus estimate of $2.38 billion. During the same period last year, the business earned ($0.19) EPS. The firm’s revenue was up 8.8% compared to the same quarter last year. On average, equities research analysts forecast that Monsanto Co. will post $4.73 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Monsanto Co. (MON) Position Boosted by US Bancorp DE” was first published by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this story can be accessed at http://www.dailypolitical.com/2016/11/29/monsanto-co-mon-position-boosted-by-us-bancorp-de.html.

A number of research analysts have recently commented on MON shares. Vetr raised shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $117.09 price objective for the company in a research note on Wednesday, August 3rd. Monness Crespi & Hardt raised shares of Monsanto from a “neutral” rating to a “buy” rating and increased their target price for the stock from $106.93 to $130.00 in a research report on Monday, August 8th. Citigroup Inc. increased their target price on shares of Monsanto from $112.00 to $116.00 and gave the stock a “neutral” rating in a research report on Friday, August 19th. Piper Jaffray Cos. reissued an “overweight” rating and set a $118.00 target price on shares of Monsanto in a research report on Sunday, August 21st. Finally, Zacks Investment Research raised shares of Monsanto from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 6th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and fifteen have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $114.06.

In related news, Director Charles S. Mcmillan acquired 3,500 shares of the business’s stock in a transaction that occurred on Monday, October 10th. The shares were acquired at an average cost of $103.23 per share, with a total value of $361,305.00. Following the purchase, the director now owns 64,009 shares of the company’s stock, valued at $6,607,649.07. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Robert T. Fraley sold 80,631 shares of the firm’s stock in a transaction that occurred on Friday, October 14th. The shares were sold at an average price of $102.04, for a total value of $8,227,587.24. Following the completion of the transaction, the executive vice president now directly owns 38,711 shares in the company, valued at $3,950,070.44. The disclosure for this sale can be found here. 0.88% of the stock is owned by corporate insiders.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).

Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.